Aly, L., Hemmer, B., & Korn, T. (2017). From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis. Curr Neuropharmacol.
Chicago ZitierstilAly, Lilian, Bernhard Hemmer, und Thomas Korn. "From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis." Curr Neuropharmacol 2017.
MLA ZitierstilAly, Lilian, Bernhard Hemmer, und Thomas Korn. "From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis." Curr Neuropharmacol 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.